NCT05946642 Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso Status UNKNOWN Phase PHASE3
NCT05930782 Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers. Status COMPLETED Phase PHASE1
NCT05913973 Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults Status COMPLETED Phase PHASE1
NCT05891236 Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults Status COMPLETED Phase PHASE1
NCT05889052 Perennial Malaria Chemoprevention (PMC) in Cameroon Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05878366 Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC) Status COMPLETED Phase NA
NCT05874869 Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in Tanzania Status COMPLETED Phase NA
NCT05856357 Perennial Malaria Chemoprevention (PMC) in Côte D'Ivoire Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05796193 Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire Status ACTIVE_NOT_RECRUITING Phase NA
NCT05690841 FocaL Mass Drug Administration for Vivax Malaria Elimination Status RECRUITING Phase PHASE3
NCT05652504 Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1) Status SUSPENDED Phase PHASE1
NCT05644067 Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country Status COMPLETED Phase PHASE1
NCT05605925 Ivermectin-artemisinin Combination Therapy for Eradication of Malaria Status UNKNOWN Phase PHASE4
NCT05604521 A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI Status TERMINATED Phase PHASE1